NEK6 and glioblastoma: Compared with corresponding normal tissues (Figure 1A), the expression of NEK6 are increased in breast invasive carcinoma (BRCA), colon adenocarcinoma (COAD), Lymphoid Neoplasm Diffuse Large B-cell Lymphoma, esophageal carcinoma (ESCA), Glioblastoma multiforme(GBM), HNSCC, kidney chromophobe (KICH), and Kidney renal papillary cell carcinoma (KIRP).